MAGE-E2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of MAGE-E2, a member of the MAGE (Melanoma Antigen Gene) protein family. MAGE-E2, like other MAGE family members, is involved in various cellular processes, including the regulation of gene expression, modulation of signaling pathways, and involvement in protein-protein interactions. MAGE proteins often function as molecular adaptors, interacting with E3 ubiquitin ligases to influence protein stability and degradation. MAGE-E2 is thought to participate in similar pathways, potentially affecting the regulation of cellular homeostasis, growth, and response to environmental stimuli. By inhibiting MAGE-E2, researchers aim to explore its specific role in these regulatory pathways and its broader influence on cellular functions.
In research settings, MAGE-E2 inhibitors provide a useful tool for investigating the molecular mechanisms by which MAGE-E2 contributes to intracellular signaling and protein regulation. Blocking the activity of MAGE-E2 allows scientists to study the downstream effects on protein ubiquitination, degradation pathways, and the transcriptional regulation of genes. This inhibition also helps reveal how MAGE-E2 interacts with other cellular proteins to modulate processes such as cell growth, differentiation, and stress responses. Additionally, MAGE-E2 inhibitors enable researchers to examine how MAGE-E2 participates in the larger MAGE family network and its influence on maintaining cellular stability. Through these studies, MAGE-E2 inhibitors contribute to a deeper understanding of the regulatory roles played by MAGE proteins and their impact on the complex signaling networks that control cellular function and adaptation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent may lead to the hypomethylation of the MAGE-E2 gene promoter, potentially resulting in the downregulation of its transcriptional activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could induce hyperacetylation of histones at the MAGE-E2 locus, thereby repressing the gene's transcription through chromatin remodeling. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 may directly inhibit DNA methyltransferases leading to decreased methylation levels of the MAGE-E2 promoter, which could reduce gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a cytidine analog, 5-Aza-2′-Deoxycytidine might incorporate into DNA and stall DNA methyltransferases, thereby leading to a decrease in MAGE-E2 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram potentially could disrupt the normal degradation pathway of MAGE-E2 protein, leading to its accumulation and subsequent downregulation at a gene level. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib may inhibit the proteasomal degradation pathway, which could lead to the destabilization of transcription factors necessary for MAGE-E2 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275's inhibition of histone deacetylase activity might lead to a repressed chromatin state at the MAGE-E2 gene, reducing its transcriptional output. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
This compound could lead to an open chromatin conformation at the MAGE-E2 promoter, reducing the gene's transcription through epigenetic silencing. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin might induce histone hyperacetylation, thereby causing transcriptional repression of the MAGE-E2 gene due to chromatin structure changes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A's inhibition of histone deacetylases could lead to decreased MAGE-E2 transcription by altering histone acetylation patterns at the gene locus. | ||||||